Skip to main content
Livermore
Livermore
ZHEN

Relay Therapeutics, Inc.

RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001812364

In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.

Q2 2024 vs. Q1 2024

How the institutions holding Relay Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of RLAY: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1892179−8
Shares132.3M89.8K126.8M−5.43M (−4.1%)
Value$1.10B$732.8K$826.8M−$271.1M (−24.7%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Relay Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to RLAY in Q2 2024
InstitutionSharesValue% of portfolio
Logos Global Management LP1,300,000$8.48M0.98%
Marshall Wace, LLP276,702$1.80M0.00%
Trexquant Investment LP184,621$1.20M0.02%
Squarepoint Ops LLC144,986$945.3K0.00%
Thrivent Financial for Lutherans120,011$782.0K0.00%
Schonfeld Strategic Advisors LLC105,518$688.0K0.01%
Lazard Asset Management LLC61,424$400.0K0.00%
Mirae Asset Global ETFs Holdings Ltd.56,111$364.2K0.00%
Corebridge Financial, Inc.53,514$348.9K0.00%
Deerfield Management Company, L.P. (Series C)46,702$304.5K0.01%
LPL Financial LLC36,382$237.2K0.00%
Walleye Capital LLC26,926$175.6K0.00%
Entropy Technologies, LP22,809$148.7K0.02%
Vontobel Holding Ltd.14,432$94.1K0.00%
EverSource Wealth Advisors, LLC5,750$47.3K0.00%
Catalyst Funds Management Pty Ltd2,500$16.3K0.00%
Quadrant Capital Group LLC1,096$7.15K0.00%
SRS Capital Advisors, Inc.1,038$6.77K0.00%
Signaturefd, LLC624$4.07K0.00%
Smartleaf Asset Management LLC306$1.93K0.00%
Ronald Blue Trust, Inc.52$4320.00%
TFC Financial Management1$70.00%

Sold out (30)

Institutions that held Relay Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of RLAY in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Jacobs Levy Equity Management, Inc1,675,403$13.9M
Point72 Asset Management, L.P.952,019$7.90M
BIT Capital GmbH152,439$1.27M
First Trust Advisors LP118,644$984.7K
Jefferies Financial Group Inc.101,563$843.0K
UBS Oconnor LLC100,039$830.3K
Public Employees Retirement System of Ohio94,341$783.0K
Quest Partners LLC81,295$674.7K
M&T Bank Corp54,250$450.7K
American International Group, Inc.46,686$387.5K
Dynamic Technology Lab Private Ltd44,632$370.0K
Connor, Clark & Lunn Investment Management Ltd.43,382$360.1K
Handelsbanken Fonder AB39,200$325.0K
Axq Capital, LP21,000$174.3K
Oxford Asset Management LLP16,018$132.9K
Centiva Capital, LP12,675$105.2K
Mackenzie Financial Corp11,571$96.0K
SEI Investments Co10,692$88.7K
Virtu Financial LLC10,461$87.0K
Jump Financial, LLC10,316$85.6K
Amundi7,775$47.5K
Metropolitan Life Insurance Co5,222$43.3K
Cubist Systematic Strategies, LLC1,229$10.2K
Group One Trading, L.P.229$1.90K
Private Wealth Management Group, LLC182$1.51K
Capital Advisors, Ltd. LLC92$1.00K
Westend Capital Management, LLC77$639
First Command Advisory Services, Inc.25$208
Farther Finance Advisors, LLC25$201
Nelson, Van Denburg & Campbell Wealth Management Group, LLC18$149

Not filed for Q2 2024 yet (2)

Institutions that held Relay Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RLAY in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG82,750$686.8K
Shell Asset Management Co7,010$46.0K